Therapeutic Approach to Inflammatory Bowel Disease Using Human Microbial Modification

Therapeutic Approach to Inflammatory Bowel Disease Using Human Microbial Modification

Bibliographic Details
Main Author:	Soo-Young Na
Format:	Article
Language:	English
Published:	Jin Publishing & Printing Co. 2021-01-01
Series:	The Korean Journal of Gastroenterology
Online Access:	http://www.kjg.or.kr/journal/list.html?pn=vol&TG=vol&s_v=77&s_n=1&year=2021

Similar Items

Evolving Therapeutic Strategies in the Inflammatory Bowel Disease
by: Soo-Young Na, et al.
Published: (2018-02-01)

Nutritional approach as therapeutic manipulation in inflammatory bowel disease
by: Jin Young Yoon
Published: (2019-10-01)

RNA Modification in Inflammatory Bowel Diseases
by: Mika Nakayama, et al.
Published: (2022-07-01)

Gut microbial metabolome in inflammatory bowel disease: From association to therapeutic perspectives
by: Mengfan Li, et al.
Published: (2022-01-01)

Asian Physician’s Perspectives on Biosimilars in Inflammatory Bowel Disease: Are We Ready to Use?
by: Soo-Young Na
Published: (2019-12-01)

Endoscopic Therapeutic Approach for Dysplasia in Inflammatory Bowel Disease
by: Sung Noh Hong
Published: (2017-09-01)

Editorial: Novel Therapeutic Approaches in Inflammatory Bowel Diseases
by: Giovanni Pallio
Published: (2023-09-01)

Dermatologic Manifestations in Inflammatory Bowel Disease
by: Hyun Yi Suh, et al.
Published: (2019-05-01)

Capsule Endoscopy in Inflammatory Bowel Disease: When? To Whom?
by: Soo-Young Na, et al.
Published: (2021-11-01)

Inflammatory bowel disease: pathogenesis, diagnosis and current therapeutic approach
by: Adrian Silaghi, et al.
Published: (2022-04-01)

Therapeutic targets in inflammatory bowel disease
by: Daniela Fluxa, et al.
Published: (2019-07-01)

Recent advances in surveillance colonoscopy for dysplasia in inflammatory bowel disease
by: Soo-Young Na, et al.
Published: (2022-11-01)

Role of epigenetic modifications and aging in inflammatory bowel disease
by: Yanting Du, et al.
Published: (2023-12-01)

Microbial-Based Therapies in the Treatment of Inflammatory Bowel Disease – An Overview of Human Studies
by: Paulo José Basso, et al.
Published: (2019-01-01)

m6A Modification Mediates Mucosal Immune Microenvironment and Therapeutic Response in Inflammatory Bowel Disease
by: Yongyu Chen, et al.
Published: (2021-08-01)

Therapeutic Drug Monitoring in Inflammatory Bowel Disease
by: Manoel Alvaro de Freitas Lins Neto, et al.
Published: (2023-12-01)

Therapeutic Oligonucleotides for Patients with Inflammatory Bowel Diseases
by: Marafini I, et al.
Published: (2020-06-01)

Catechins and Their Therapeutic Benefits to Inflammatory Bowel Disease
by: Fei-Yan Fan, et al.
Published: (2017-03-01)

Gut Microbial Metabolite Butyrate and Its Therapeutic Role in Inflammatory Bowel Disease: A Literature Review
by: Neeraja Recharla, et al.
Published: (2023-05-01)

Treatment of Inflammatory Bowel Disease in Elderly Patients – What Are Different and What Should We Know?
by: Soo-Young Na
Published: (2021-05-01)

Ophthalmologic manifestations in patients with inflammatory bowel disease
by: Hye Jin Lee, et al.
Published: (2017-07-01)

New Insights on CD8+ T Cells in Inflammatory Bowel Disease and Therapeutic Approaches
by: Rosaely Casalegno Garduño, et al.
Published: (2021-10-01)

Microbial Disruptions in Inflammatory Bowel Disease: A Comparative Analysis
by: Ma J, et al.
Published: (2024-04-01)

Inflammatory Bowel Diseases: Host-Microbial-Environmental Interactions in Dysbiosis
by: Catherine Colquhoun, et al.
Published: (2020-05-01)

Translating immunology into therapeutic concepts for inflammatory bowel disease
by: Uhlig, HH, et al.
Published: (2018)

Ferroptosis: A therapeutic opportunity of inflammatory bowel disease
by: Yulin Ye, et al.
Published: (2024-04-01)

Therapeutic Applications of Extracellular Vesicles in Inflammatory Bowel Disease
by: Sang Hyun Kim, et al.
Published: (2024-01-01)

Inflammasome Regulation: Therapeutic Potential for Inflammatory Bowel Disease
by: Qiuyun Xu, et al.
Published: (2021-03-01)

Gut microbiome–based therapeutics in inflammatory bowel disease
by: Kelly A. Hu, et al.
Published: (2023-04-01)

The Gut Microbiota in the Pathogenesis and Therapeutics of Inflammatory Bowel Disease
by: Tao Zuo, et al.
Published: (2018-09-01)

The microbiota in inflammatory bowel disease: current and therapeutic insights
by: Lane ER, et al.
Published: (2017-06-01)

Predictive approaches in inflammatory bowel disease
by: Philippe Pinton
Published: (2022-02-01)

Mesenchymal Stem Cell-derived Exosomes: Novel Therapeutic Approach for Inflammatory Bowel Diseases
by: Cheng-mei Tian, et al.
Published: (2023-01-01)

Therapeutic Implications of Diet in Inflammatory Bowel Disease and Related Immune-Mediated Inflammatory Diseases
by: Yan Jiang, et al.
Published: (2021-03-01)

Patients with inflammatory bowel disease exhibit dysregulated responses to microbial DNA.
by: Naomi S C Hotte, et al.
Published: (2012-01-01)

Microbial imbalance in inflammatory bowel disease patients at different taxonomic levels
by: Mohammad Tauqeer Alam, et al.
Published: (2020-01-01)

Gut microbiota in pathophysiology, diagnosis, and therapeutics of inflammatory bowel disease
by: Himani Pandey, et al.
Published: (2024-01-01)

Therapeutic Potential for Sphingolipids in Inflammatory Bowel Disease and Colorectal Cancer
by: Keila S. Espinoza, et al.
Published: (2024-02-01)

Inflammatory Bowel Disease Treatments and Predictive Biomarkers of Therapeutic Response
by: Duaa Ahmed Elhag, et al.
Published: (2022-06-01)

Adrenomedullin: A Novel Therapeutic for the Treatment of Inflammatory Bowel Disease
by: Shinya Ashizuka, et al.
Published: (2021-08-01)